Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose–response relations and strain differences

Jin-Shuen Chen1,3, Ann Chen4, Li-Chien Chang2, Wun-Shaing Wayne Chang5, Herng-Sheng Lee4, Shih-Hua Lin3 and Yuh-Feng Lin3

1 Graduate Institutes of Medical Sciences, 2 School of Pharmacy, National Defense Medical Center, 3 Division of Nephrology, Department of Internal Medicine, 4 Department of Pathology, Tri-Service General Hospital and5 National Health Research Institutes, Taipei, Taiwan

Correspondence and offprint requests to: Yuh-Feng Lin, MD, Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital 325, Sec. 2, Cheng-Kung Road, Neihu 114, Taipei, Taiwan, Republic of China. Email: linyf{at}ndmctsgh.edu.tw



   Abstract
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Background. Few well-characterized animal models have been developed to study the pathogenesis of membranous nephropathy (MN). We have developed a mouse model of MN induced by cationic bovine serum albumin (cBSA), and examined the role of genetic background on disease induction by assessing different mouse strains.

Methods. cBSA in an optimum dose was given intravenously to 8-week-old female ICR, BALB/c and C57BL/6 mice for 4 weeks. The disease state was verified by renal histopathology as well as by serum and urine metabolic profiles. Serum concentrations of anti-cBSA immunoglobulins (Igs) and circulating immune complex (CIC) were assayed to study the mechanisms of initiation and progression. T-helper (Th) cell subsets in peripheral blood were examined using flow cytometry, and the Th1/Th2 subset distribution was determined by comparing the serum concentrations of IgG1 and IgG2a, using quantitative heterologous interpolation enzyme-linked immunosorbent assays.

Results. Only ICR and BALB/c mice developed the typical clinical and pathological patterns of MN in response to an optimum dose of cBSA. Disease induction was dose related and strain specific. The serum concentrations of anti-cBSA were significantly higher in the strains that developed MN, but there were no differences in CIC concentrations. This suggests that in situ immune-complex glomerulonephritis may be involved in the development of MN. The Th2 type immune response may predominate in the ICR and BALB/c mice models, as the serum concentration of IgG1 was higher than that of IgG2a; moreover Th2 type strain specificity was necessary for the development of MN.

Conclusions. This improved mouse model of MN induced by cBSA more closely duplicates human MN than the other available models. Disease generation is antigen dose related and strain specific.

Keywords: cationic bovine serum albumin; circulating immune complex; membranous nephropathy; strain difference; T-helper lymphocytes



   Introduction
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Membranous nephropathy (MN) has been defined as granular subepithelial deposition of IgG immune complexes along the glomerular basement membrane (GBM) [1]. Such a process could be initiated from in situ formation of antigen-induced immune complexes, with the nephritogenic antigens being either endogenous (in situ) or exogenous [1,2]. The progression of MN is characterized by diffuse GBM thickening and a predominant T-helper (Th) 2 type immune response [3], followed by glomerular capillary wall (GCW) damage and severe proteinuria, finally progressing to renal function impairment. However, the detailed mechanisms of MN initiation and progression remain unclear. To explore these processes, a suitable animal model is necessary.

One of the most frequently used models of human MN is Heymann's nephritis, using the rat [1,4]. Alternative models are induced by repeated doses of cationic bovine serum albumin (cBSA) in the dog [5], cat [6], rabbit [7–9] and rat [10,11] (Table 1). However, there are few well-characterized mouse models for the study of human MN although mice offer the advantage of being cheaper, easier to manipulate, and suitable for ample experimental applications. Here we have developed a mouse model of MN using cBSA, and have characterized it clinically, pathologically and genetically. We also evaluated the susceptibility of various strains of mice in response to different doses of cBSA.


View this table:
[in this window]
[in a new window]
 
Table 1. Animal membrane nephropathy models induced by cationic bovine serum

 


   Materials and methods
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Animals
Specific pathogen-free female 8-week-old ICR (outbred), BALB/c (inbred) and C57BL/6 (inbred) mice weighing ~20 g were purchased from the Laboratory Animal Center, National Taiwan University College of Medicine. The animals were housed in conventional cages and fed a standard diet in the Laboratory Animal Center of the National Defense Medical Center. All animal work was conducted in accordance with institutional guidelines.

Preparation of cBSA
The cBSA was prepared as previously described [5] with slight modification. Briefly, 200 g of crystallized bovine serum albumin (Sigma, St Louis, MO) was dissolved in 1.2 ml of distilled water. Anhydrous ethylenediamine (EDA) (Sigma) was prepared by mixing 2.68 ml of EDA and 20 ml of distilled water. The pH was adjusted to 4.75 with 6 N HCl and the solution cooled to 25°C. This EDA solution was added slowly to the BSA solution followed by 150 mg of 1-ethyl-3-[(3-dimethylaminopropyl)-carbodiimide hydrochloride] (EDC) (Sigma) with continuous stirring for 4 h. The product was purified using the pH-dependent binding technique [12]. The reaction solution was applied to a 1 ml Econo Pac® High S cationic ion-exchange column (BioRad, Hercules, CA). After binding of BSA to the ion-exchange beads, the column was washed with 10 ml of pH 6.8 phosphate buffer (40 mM) to remove the non-reacted BSA. Subsequently, the modified BSA was eluted with 5 ml of 40 mM phosphate buffer (pH 10.6). All collections were then pooled, concentrated and reconstituted with saline. Prior to use, the final protein concentration was measured using UV absorbance at 280 nm.

Experimental design
To determine the optimum dose of cBSA for MN induction, ICR mice (10 in each group) received the antigen intravenously at 1, 3, 5, 7 and 9 mg/kg, three times per week every other day (tiw), two weeks after immunization by the same route with 0.2 mg of cBSA emulsified in an equal volume of complete Freund's adjuvant. The severity of proteinuria was measured using urine strips (Bayer Diagnostics, Bridgend, South Wales, UK). When all members of a group developed grade 4 proteinuria, that minimum dose was defined as the optimum. BALB/c and C57BL/6 mice received the same protocol to define the ideal dose for those strains.

Based on these titration results, we designed a study to clarify the initiation and progression of cBSA-induced MN. Eight-week-old ICR mice were divided into four groups (10 mice in each group): control (C); immunization (I); low dose (L); and high dose (H). Groups I, L and H were immunized as described. Two weeks later, groups L and H were injected intravenously with 1 and 7 mg/kg of cBSA, tiw, respectively. Group I received a saline injection after the immunization. Group C did not receive immunization but mice were given saline injections on the same schedule as group H. For the BALB/c and C57BL/6 strains, only the groups with successfully induced MN and controls were investigated. After 4 weeks, the animals were killed, and we collected blood, urine and kidney samples for analysis.

Blood and urine metabolic data
Urine samples were collected in a metabolic cage 1 day before death, microcentrifuged and stored at –70°C until assayed. Before death, blood samples were taken from the retro-orbital venous plexus, microcentrifuged, and stored at –70°C until assayed.

Proteinuria was measured as the ratio of urinary protein (mg/ml) to urine creatinine (Cr) (mg/dl) (Up/UCr). Urinary protein was quantitatively determined using a BCA protein assay kit (Pierce, Rockford, IL). Urine Cr was measured using a creatinine assay kit (Sigma). Concentrations of blood urea nitrogen (BUN), Cr, albumin and total cholesterol (T. chol) were determined with kits from Sigma. All assays were performed in duplicate according to the manufacturer's instructions.

Histopathology of renal tissues
Renal tissues were snap frozen and fixed in Carson–Millonig's solution for fluorescence and electron microscopy (EM) and 10% formalin for light microscopy. Formalin-fixed tissues were dehydrated in a graded ethanol series and embedded in paraffin wax. Sections (3 µm) were stained with haematoxylin and eosin (H&E). Frozen tissues were sectioned, dried in air, fixed in acetone for 10 min at room temperature, and washed with PBS prior to incubation with fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse immunoglobulin (Ig) A, IgG, IgM and C3 (Capple, Durham, NC). The sections were observed using a fluorescence photomicroscope (Olympus, Tokyo, Japan). Semi-quantitative evaluation of fluorescence was performed as previously described [13]. For EM examination, small sections of fixed renal tissue were washed in Carson–Millonig's solution, post-fixed for 1 h in 1% aqueous osmium tetroxide, dehydrated in a graded alcohol series, and embedded in Epon resin. Ultrathin sections were cut using diamond knives, double stained with uranyl acetate and lead citrate, and examined using a transmission electron microscope (JEM-1230; JEOL, Peabody, MA).

Study of glomerular polyanions
Glomerular polyanions were investigated after staining according to Mowry [13,14] using colloidal iron staining for light microscopy. Renal samples were processed as described above for H&E staining. Deparaffinized sections were stained for 2 h in colloidal iron solution, followed by three rinses with 30% acetic acid (pH 1.5). The specimens were incubated for 20 min in a freshly prepared solution of 1% hydrochloric acid and 1% potassium ferrocyanide. Sections were then observed using an optical photomicroscope (Olympus). Semi-quantitative evaluation of glomerular staining was performed as previously reported [13]. The values ranged from 0 to a maximum of 300.

Serum concentrations of anti-cBSA Igs, IgG1 and IgG2a antibody, and circulating immune complex
The serum concentrations of the anti-cBSA Igs, IgG1, and IgG2a, were measured using an enzyme-linked immunosorbent assay (ELISA), which was modified from a previous method [11,15]. In brief, 96 well polyvinyl chloride microtitration plates (FALCON; Becton Dickinson and Co., Franklin Lakes, NJ) were coated with cBSA, 0.5 µg/well, in coating buffer (15 mM Na2CO3, 35 mM NaHCO3, 10 mM MgCl2, pH 9.6), incubated overnight at 4°C, and then washed five times with washing buffer (150 mM NaCl, 1/1000 Tween-20, pH 7.4). The plates were blocked with 300 µl of 1% goat serum albumin for 30 min at room temperature, followed by five washes with washing buffer. The serum samples, diluted in ELISA buffer (150 mM NaCl, 10 mM Na2HPO4, 1 mM KH2PO4, 2.6 mM KCl, 0.5% BSA, 1/1000 Tween-20, pH 7.4), were assayed at different dilution for Igs, IgG1 and IgG2a (Igs, 1/10 000; IgG1, 1/10 000–1/640000; IgG2a, 1–1/640 000). After 1 h incubation at room temperature, the plates were washed five times with washing buffer. Then, 100 µl aliquots of horseradish peroxidase-conjugated goat anti-mouse Igs (DAKO EnVisionTM Doublestain system; DAKO, Carpinteria, CA), IgG1 and IgG2a (mouse IgG1 and IgG2a quantitation kit; Bethyl Laboratories Inc., Montgomery, TX), each diluted 1/1000, 1/5000 and 1/5000 with ELISA buffer, were added. After 1 h of incubation at room temperature, the plates were washed again five times, 100 µl of 3,3',5,5'-tetramethybenzidine (Chemicon International Inc.; Temecula, CA) substrate solution was added into each well for 15 min at room temperature, and the reaction was stopped with 50 µl of 2 N H2SO4. The optical density (OD) was read at 450 nm on an automated microplate reader (MRX; Dynex Technology, Chantilly, VA). The absorbance of the test sample blank was subtracted from all data for each plate. Data were expressed as OD at 450 nm. The IgG1 and IgG2a mouse reference sera (mouse IgG1 and IgG2a quantitation kits) were used to construct a standard curve according to the manufacturer's instructions.

For CIC detection, plates coated with C1q to detect CIC (Alpha Diagnostic International Inc., San Antonio, TX) were used with sera diluted 1/10, 1/20, 1/40, 1/80, 1/160 and 1/320 in the sample buffer. Subsequent procedures were performed according to the manufacturer's instructions. Data were read and expressed as described above.

Preparation of peripheral blood and flow cytometry
Before death, blood samples were taken from the retro-orbital venous plexus, ~500 µl being collected in an EDTA tube and mixed by inversion. Subsequently, 10 ml of 1 N NH4Cl was added to whole blood, and the mixture was incubated for 10 min at room temperature before centrifugation at 750 g at 4°C for 6 min. Cells were washed twice with 0.2% BSA in 1 M PBS. More than 90% cell viability was verified using the Trypan Blue exclusion method, and the cell concentration was determined.

A sample of 1.0–2.0 x 105 cells was incubated for 30 min on ice with cell surface monoclonal antibodies (MoAbs) against T cells. Dual colour immunofluorescence (IF) was performed using phycoerythrin (PE)-conjugated rat anti-mouse CD3 (PharMingen, San Diego, CA) and FITC-conjugated rat anti-mouse CD4 and CD8 (Serotec, Kidlington, Oxford, UK). The stained cells were washed with 1 M PBS and then analysed by fluorescence-activated cell sorting (FACS) using a FACScan flow cytometer (Becton-Dickinson). A minimum of 10 000 events was acquired, and the data were analysed using CellQuest software (version 3.3).

Statistical analyses
Results are expressed as mean±SEM. Statistical significance was calculated by one-way ANOVA for multiple comparisons and Student's t-test for unpaired data. P < 0.05 was regarded as significant.



   Results
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Optimum dose of cBSA for induction of MN
Five regimens were used to determine the optimum dose of cBSA for induction of MN. As shown in Table 2, all ICR mice receiving 7 mg/kg exhibited severe proteinuria (grade 4 using urine strips and calibrated by the UP/UCr ratio). However, none of the ICR mice given 1 mg/kg developed proteinuria, and only some of those receiving 3 or 5 mg/kg developed it: 10 and 50%, respectively. Most ICR mice in the group given 9 mg/kg died. These results suggest a dose-related effect in the induction of MN. The dose of 7 mg/kg was therefore used for further study. Applying similar titration protocols to BALB/c and C57BL/6 mice showed the ideal dose to induce MN in BALB/c was 13 mg/kg, whereas MN could not be induced reliably in the C57BL/6 strain.


View this table:
[in this window]
[in a new window]
 
Table 2. Percentage of proteinuria development after different doses of cBSA for 4 weeks in ICR mice (10 mice/each group)

 
Metabolic data for serum and urine
Metabolic data for serum and urine samples in the ICR and BALB/c mice that developed MN showed similar patterns. Only the results for ICR mice are shown in this study. As shown in Table 3, the mean serum Alb. and T. chol concentrations of group H were significantly lower and higher, respectively, than those of group C (P<0.05). For BUN and Cr data, there were no significant differences between groups H and C. In addition, the Up/UCr, ratio, representing the severity of proteinuria, was significantly higher in group H (P<0.05). Thus, group H had developed hyperlipidaemia, hypoalbuminaemia and severe proteinuria. On the other hand, the metabolic data for groups I and L showed no significant differences from those for group C.


View this table:
[in this window]
[in a new window]
 
Table 3. Metabolic data of control (C), immunization (I), low dose (L) and high dose (H) groups in ICR mice (10 mice/each group)

 
Morphology
Typical MN pathological findings were demonstrated in BALB/c and ICR mice. Only the ICR strain findings are shown here.

Light microscopy
Thickness of the GBM for groups I and L was the same as for group C (data not shown), but group H exhibited the typical MN morphologic pattern, namely, diffuse thickening of the GBM and no significant mesangial proliferation in comparison with group C (Figure 1A).



View larger version (57K):
[in this window]
[in a new window]
 
Fig. 1. Representative renal histopathological findings in the ICR strain mouse model of MN. (A) A glomerulus shows diffuse basement membrane (GBM) thickening (arrow) and normal mesangial cell distribution (small arrow) (H&E staining; original magnification x 400). (B) Immunofluorescence stain for IgG (x 400). Grade III granular fluorescent intensity (arrow) is seen along a capillary wall in a glomerulus. (C) Electron micrograph (x 12 000) showing part of a capillary loop. The GBM discloses severe irregular thickening of the laminae rarae, interna and externa, and the subepithelial deposits (arrows) are layered and more confluent than normal. The GBM shows spikes (small arrows) extending between the deposits and podocyte foot processes were reduced. CAP, capillary; G, glomerular basement membrane; P, podocyte; U, urinary space.

 
Immunofluorescence microscopy
IF staining for group H mice showed strong granular fluorescent intensity of IgG (average mean score 300) and C3 (average mean score 200) along the GCW (Figure 1B). IgA and IgM were both negative by IF.

Electron microscopy
Ultrastructurally, in group H kidneys the basement membrane showed severe irregular thickening of the laminae rarae, interna and externa, and subepithelial deposits were layered and more confluent (Figure 1C), suggesting glomerular size selectivity defect [16]. GBM spikes were observed extending between the deposits and there was loss of podocyte foot processes.

Colloidal iron staining
There was a reduced intensity of blue staining along the GCW, indicating the loss of glomerular anions. Staining was moderately attenuated in group H kidneys (Figure 2A) compared with group C (Figure 2B), and the total mean intensity of staining was decreased to approximately 120 on a semi-quantitative scale [13].



View larger version (104K):
[in this window]
[in a new window]
 
Fig. 2. Identification of glomerular polyanions in the ICR strain mouse model of MN, using colloidal iron staining (x 400). The intensity of blue staining along the capillary wall represents the concentration of glomerular polyanions. Staining in group H (A) shows moderate attenuation compared with group C (B).

 
In situ immune-complex glomerulonephritis
To determine whether the cBSA-induced MN in the mice was true in situ immune-complex glomerulonephritis (GN), the serum concentrations of anti-cBSA Igs and CIC were examined in the ICR mice. The assay precision of ELISA was kept between 5 and 10%. As shown in Figure 3A, the titres of anti-cBSA Igs in groups I, L and H were all significantly higher than those of group C (P<0.05). However, there were no statistical differences between the titres of groups I, L and H. This suggests that this measure may not be an absolute indicator of MN formation, given that only group H developed typical MN. The serum CIC concentrations were subsequently measured for groups C and H and showed no statistical difference (data not shown). Thus, there was no increase in serum CIC in the MN mouse model. Although IF staining showed immune-complex deposition, the mice that developed MN expressed higher amounts of Igs and no significant change in CIC, so the cBSA-induced MN may indeed be categorized as in situ immune-complex GN.



View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3. Comparison of anti-cBSA Igs serum concentrations in ICR strain mice. The total serum Igs in groups I, L and H were not statistically different but were significantly higher than in group C. The serum dilution was 1/10 000. Data are expressed as optical density at 450 nm. Results are shown as mean±SEM. *P<0.05 in comparison with group C.

 
Alterations of T-lymphocyte subtype distribution in peripheral blood
The development and progression of MN generally involve alterations among T-lymphocyte populations [15]. We analysed the correlations between the expression of T-lymphocyte populations and MN from the phenotypes of T-lymphocyte subpopulations in peripheral blood using FACS. The percentages of CD3+/CD4+ and CD3+/CD8+ subtypes in ICR mice showed no significant difference between groups C and H (CD3+/CD4+, 43.37±3.39 vs 39.98±3.08; CD3+/CD8+, 22.52±3.76 vs 27.01±4.54). Similarly, in BALB/c mice, there were no statistical differences between the MN and control groups in percentages of subtypes (CD3+/CD4+, 24.54±3.95 vs 27.73±5.31; CD3+/CD8+, 15.05±2.69 vs 14.33±5.68).

Polarization of Th cell subsets
Two strategies were used to evaluate the polarization of Th subsets in our MN mouse models. First, the two inbred strains, BALB/c and C57BL/6, each with a distinct genetic background, were studied. BALB/c is a strain carrying the Th2 subset; however, C57 carries Th1 [17]. We found that MN could be induced in BALB/c, but not in C57 mice. The Th2 subset response may thus play an important role in the development of MN. Secondly, the functionally distinct Th1 and Th2 subsets can be differentiated according to individual cytokine production or subsequent cytokine effects. Th1 regulates Ig switching to the IgG2a type, whereas Th2 enhances IgG1 secretion [15]. We therefore assessed Th functions in our successful MN mouse models—the ICR and BALB/c strains—by measuring the serum concentrations of IgG1 for Th2 and of IgG2a for Th1. Using quantitative heterologous interpolation ELISA [18], we found that the reference curves constructed with IgG1 and IgG2a were similar; the data subsequently were applied to interpolate test samples. As shown in Figures 4A and B, no matter what the sample dilution, the slope, intercept and R2 of the regression lines for IgG1 were significantly higher than those of IgG2a in ICR and BALB/c mice. Thus, the MN mouse model appeared attributable to a Th2 response.



View larger version (16K):
[in this window]
[in a new window]
 
Fig. 4. Identification of Th cell subset polarization in the ICR and BALB/c strain mouse models of MN, showing comparisons of optical density (OD) intensities of IgG1 and IgG2a. The serum was serially diluted (IgG1, 1/10 000–1/640 000; IgG2a, 1–1/640 000). The serum dilution scale has been log10 transformed and is plotted vs OD, which is expressed as means of triplicate measurements. Slope, intercept and R2 values of the regression line for IgG1 are higher than those for IgG2a, in both ICR (A) and BALB/c (B) strains.

 


   Discussion
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 
Although the mechanisms of initiation and progression of human MN remain largely unknown, considerable evidence suggests that the full spectrum of patterns includes in situ subepithelial deposition of immune complexes accompanied by diffuse GBM thickening, nephrotic syndrome, and the predominance of the Th2 immune response [1,3]. Here we report the development of a new MN mouse model induced by cBSA. Clinically, the animals developed hypoalbuminaemia, hypercholesterolaemia and severe proteinuria. Morphologically, they exhibited dense subepithelial deposits and diffuse basement membrane thickening. Exogenous cBSA antigen had a dose-related influence on disease induction and may have induced in situ immune-complex GN. Moreover, this mouse MN model may display Th2 polarization and strain-specific dependence. Thus, this model exhibits great similarity to human MN disease.

The cBSA antigen has been utilized to induce MN in various animals, as summarized and compared with our model in Table 1. For all models, both initial antigen stimulation and continuous boosting doses are required for disease induction. Among these models, all animals develop proteinuria except the dog. Our mice also demonstrated hypoalbuminaemia and hypercholesterolaemia, suggesting that this model exhibits clinical manifestations similar to those of human MN with nephrotic syndrome. Histopathologically, all animal models display GBM thickening, IgG granular deposition and subepithelial deposits. However, variants of MN are sometimes observed, including inflammatory-cell infiltration, segmental endocapillary proliferation, and mesangial cells proliferation. Our mice did not develop these variants to any significant extent. Such variants of MN might reflect the purity of the cBSA antigen. The heterogeneity of the antigenic charge distinctly affects its ability to cause damage: the more cationic the immunogen, the more nephritogenic it is and the greater its tendency to produce a typical MN pattern [8,19]. The cBSA preparations previously used were only characterized by polyacrylamide gel flat bed electrophoresis and fast protein liquid chromatography [5,8,9], which could not exclude the presence of native anionic and slightly cationic BSA. Because we used a more homogenous cBSA preparation purified by the pH-dependent binding technique [12], our model disclosed greater consistency.

Antigen quantity also seems to be a cofactor influencing MN induction and a threshold exposure to antigen is needed for induction [20]. Our experience of induction was consistent with this. In preliminary studies, we found that ICR mice given a low dose of cBSA (3 mg/kg) could recover from proteinuria if administration was stopped (data not shown). Human MN has a variable course, and 15–60% of patients exhibit spontaneous remission and complete recovery without treatment [21]. Although the mechanisms responsible for this variable course remain unclear, our results suggest that lower antigen exposure might increase the chance of spontaneous remission. We speculate that the antigen source, dose and exposure duration are factors in the pathological and clinical diversity of MN.

The antigen-associated renal injury mostly involves two mechanisms: initiation and progression. Initiation is strongly suggested to be a consequence of circulating autoantibody against antigen located on the epithelial side of the glomerular capillaries [22], indicating in situ immune-complex GN. Consistent with this idea, the mechanism of initiation in this MN mouse model is proposed to be deposition of cBSA antigen on the subepithelial side, followed by specific antibody aggregation leading to in situ immune-complex GN. With regard to MN progression, it is proposed that immune complexes, once deposited in the glomerulus, generate a cascade of local injury events that contribute to reduced glomerular size and charge selectivity [22,23] and excessive protein leakage. In our model, combined impairment of charge and size selectivity was responsible for proteinuria, as was also demonstrated by colloidal iron staining and ultrastructural studies. Another mechanism of accelerated MN progression is a T-cell-related systemic immune response. The Th2 type, a predominantly humoral immune response is strongly suggested [3]. In our study, MN was successfully induced in the strain of mice carrying Th2, but not in the Th1-carrying strain. This suggests that a genetic background with a predisposition for Th2 cells may determine the successful induction and progression of MN. Moreover, when analysing IgG1 and IgG2a, in our model, the IgG isotype profile showed a bias for IgG1. Polarization to a Th2 type immune response in the initiation and progression of our MN mouse model is thus likely. The CD4 and CD8 T-cell phenotypes showed no statistically significant changes between baseline and after MN induction. Various studies of the changes in T-cell subsets in MN have not shown consistent results [3,24,25], for unknown reasons.

The Heymann's nephritis rat is a generalized model with morphological and functional aspects similar to those of human MN [4]. However, it has rarely been applied to the mouse. Our MN model induced by cBSA not only provides a new model to study the process of MN, but also shows strain-specific difference in the establishment of disease. These models, including inbred and outbred strains of mice, offer promise for studies of the initiation, progression and treatment of human MN. Moreover, as we found a dose-related effect on induction, this model may be suitable for investigation of the varied course of MN.



   Acknowledgments
 
We would like to thank Ms Ko-Ying Tang and Ms Hsin-Yi Tsai for their technical support. This work was supported by grants from the National Defense Medical Center, Tri-Service General Hospital, and National Science Council, Taiwan, ROC (TSGH-C92-64, NSC 90-2314-B-016-074).

Conflict of interest statement. None.



   References
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 References
 

  1. Falk RJ, Jennett JC, Nachman PH. Membranous nephropathy. In: Brenner BM, ed. The Kidney. WB Saunders, Philadelphia, PA 2000; 1284–1292
  2. Maruyama S, Cantu E, Demartino C et al. Membranous glomerulonephritis induced in the pig by antibody to angiotensin-converting enzyme: considerations on its relevance to the pathogenesis of human idiopathic membranous glomerulonephritis. J Am Soc Nephrol 1999; 10: 2102–2108[Abstract/Free Full Text]
  3. Hirayama K, Ebibara I, Yamamoto S et al. Predominance of type-2 immune response in idiopathic membranous nephropathy. Nephron 2002; 91: 255–261[CrossRef][ISI][Medline]
  4. Kerjaschki D, Farquhar MG. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats. J Exp Med 1983; 197: 667–686[CrossRef]
  5. Wright NG, Mohammed NA, Eckersall DD, Nash AS. Experimental immune complex glomerulonephritis in dogs receiving cationized bovine serum albumin. Res Vet Sci 1985; 38: 322–328[ISI][Medline]
  6. Nash AS, Mohammed NA, Wright NG. Experimental immune complex glomerulonephritis and the nephritic syndrome in cats immunized with cationized bovine serum albumin. Res Vet Sci 1990; 49: 370–372[ISI][Medline]
  7. Border WA, Ward HJ, Kamil ES, Coben AH. Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J Clin Invest 1982; 69: 451–461[ISI][Medline]
  8. Bass PS, Darke AF, Wang Y, Thomas JH, Davies DR. Cationization of bovine serum albumin alters its conformation as well as its charge. Lab Invest 1990; 62: 185–188[ISI][Medline]
  9. Bass PS, Wang Y, Nawab MAL, Evans B, Thomas H, Davies DR. The effect of cyclosporin A on cationized bovine serum albumin-induced nephropathy in NZW rabbits. J Pathol 1992; 167: 41–47[CrossRef][ISI][Medline]
  10. Soares VA, Fan CD, Ward H. Mesangial overload in experimental membranous nephropathy. Brazilian J Med Biol Res 1992; 25: 477–486[ISI][Medline]
  11. Kobayashi M, Muro K, Yoh K, Kondoh M et al. Effects of FK506 on experimental membranous glomerulonephritis induced by cationized bovine serum albumin in rats. Nephrol Dial Transplant 1998; 13: 2501–2508[Abstract]
  12. Yang VC, Langer R. pH-dependent binding analysis, a new and rapid method for isoelectric point estimation. Anal Biochem 1985; 147: 148–155[ISI][Medline]
  13. Chen A, Sheu LF, Ho YS et al. Experimental focal segmental glomerulosclerosis in mice. Nephron 1998; 78: 440–452[CrossRef][ISI][Medline]
  14. Mowry RW. The special value of methods that colour both acidic and vicinal hydroxyl groups in the histochemical study of mucins with revised directions for colloidal iron stain: the use of alcian blue G8X and their combination with the periodic acid-Schiff reaction. Ann N Y Acad Sci 1963; 106: 402–423[ISI]
  15. Kaplan C, Valdez JC, Chandrasekaran R et al. Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis. Arthritis Res 2002; 4: 54–58[ISI][Medline]
  16. Myers BD. Determinants of the glomerular filtration of macromolecules. In: Massry SG, Glassock RJ, eds. Textbook of Nephrology. Williams & Wilkins, Baltimore, MO 1995; 60–65
  17. Shi Z, Wakil AE, Rockey DC. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA 1997; 94: 10663–10668[Abstract/Free Full Text]
  18. Hamilton RG, Adkinson NF Jr. Quantitative aspects of solid phase immunoassays. In: Kemeny DM, Challacombe SJ, eds. ELISA and Other Solid Phase Immunoassays. John Wiley, Chichester, 1988; 57–84
  19. Iskandar SS, Zhang J, Rodriguez E. Nephropathy induced in a nephritis-resistant inbred mouse strain with the use of a cationized antigen. Am J Pathol 1986; 123: 67–72[Abstract]
  20. Breysse P, Couser WG, Alpers CE, Nelson K, Gaur L, Johnson RJ. Membranous nephropathy and formaldehyde exposure. Ann Intern Med 1994; 120: 396–397[Free Full Text]
  21. Cattran DC. Membranous nephropathy: quo vadis? Kidney Int 2002; 61: 349–350[CrossRef][ISI][Medline]
  22. Ravnskov U. The subepithelial formation of immune complexes in membranous glomerulonephritis may be harmless and secondary to toxic or allergic factors. Scand J Immunol 1998; 48: 469–474[ISI][Medline]
  23. Ramjee G, Coovadia HM, Adhikari M. Direct and indirect tests of pore size and charge selectivity in nephrotic syndrome. J Lab Clin Med 1996; 127: 195–199[CrossRef][ISI][Medline]
  24. Cagnoli L, Tabacchi P, Pasquali S, Cenci M, Sasdelli M, Zuchelli P. T cell subset alterations in idiopathic glomerulonephritis. Clin Exp Immunol 1982; 50: 70–76[ISI][Medline]
  25. Zucchelli P, Ponticelli C, Cagnoli L, Aroldi A, Beltrandi E. Prognostic value of T lymphocyte subset ratio in idiopathic membranous nephropathy. Am J Nephrol 1988; 8: 15–20[CrossRef][ISI][Medline]
Received for publication: 5.11.03
Accepted in revised form: 23. 6.04





This Article
Abstract
FREE Full Text (PDF)
All Versions of this Article:
19/11/2721    most recent
gfh419v1
Alert me when this article is cited
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in ISI Web of Science
Similar articles in PubMed
Alert me to new issues of the journal
Add to My Personal Archive
Download to citation manager
Disclaimer
Request Permissions
Google Scholar
Articles by Chen, J.-S.
Articles by Lin, Y.-F.
PubMed
PubMed Citation
Articles by Chen, J.-S.
Articles by Lin, Y.-F.